Abaxis

Abaxis

The Piccolo Xpress® is an extremely easy-to-use and reliable blood analyzer – but inside that small instrument lies sophisticated technology. The Piccolo Xpress® technology was originally developed for NASA by the scientists at the Oak Ridge National Laboratory. Abaxis acquired the technology and finalized the development of the Piccolo analyzer, which was FDA cleared for human use in 1995. Zoetis acquired Abaxis in 2018 and is focused on driving new levels of efficiency, reliability and excellence for point-of-care diagnostics. It is our mission to help drive more efficient care for the world's populations through easy, accurate and fast diagnostic results.

Chemistry Testing, Chemistry Systems, Chemistry Diag/Reagents/Kits

No

Distributor/Agent/Representative

The Piccolo Xpress® point-of-care chemistry analyzer delivers lab-accurate results on-site in 12 minutes. With the Piccolo Xpress® deployed in your clinical operations, the process of diagnosis and treatment planning becomes faster and simpler. Medical professionals around the world have come to rely on the Piccolo Xpress® for the rapid point of care diagnostic results they need to improve the care they provide for their patients.

Bangladesh, Brazil, Egypt, India, Indonesia, Philippines, Turkey